ANVS
ANVS
NYSE · Biotechnology

Annovis Bio

$1.96
+0.02 (+1.03%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +637.8% upside
Low Target $8.98
Average Target $14.46
High Target $17.59
Current Price $1.96
Current
$1.96
Target
$14.46
$8.98 $14.46 avg $17.59
Scenario Analysis
Bear Case
$8.98
358.2%
Low target
Base Case
$14.46
+637.8%
Avg target
Bull Case
$17.59
+797.4%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$5.50
-64.4% from high
52-Week Low
$1.54
+27.2% from low
Target vs 52W High
$14.46
+162.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +20.5%
AMGN
Amgen Inc
Hold 44 48% $190.87 -42.2%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +178.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +2.1%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -88.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -65.2%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -23.9%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.0%